Detailed information for compound 1988573

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 464.408 | Formula: C22H23Cl2N3O2S
  • H donors: 4 H acceptors: 3 LogP: 5.68 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: N[C@@H]1CC[C@H](CC1)Nc1c(cnc2c1cc(cc2)c1cc(Cl)c(c(c1)Cl)O)[S+](C)[O-]
  • InChi: 1S/C22H23Cl2N3O2S/c1-30(29)20-11-26-19-7-2-12(13-9-17(23)22(28)18(24)10-13)8-16(19)21(20)27-15-5-3-14(25)4-6-15/h2,7-11,14-15,28H,3-6,25H2,1H3,(H,26,27)/t14-,15-,30?
  • InChiKey: LMMMURGEOQJINQ-FQQABSRCSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens maternal embryonic leucine zipper kinase Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis maternal embryonic leucine zipper kinase Get druggable targets OG5_133787 All targets in OG5_133787
Brugia malayi Protein kinase domain containing protein Get druggable targets OG5_133787 All targets in OG5_133787
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_133787 All targets in OG5_133787
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_133787 All targets in OG5_133787
Schistosoma japonicum gsx family homeobox protein; serine/threonine kinase Get druggable targets OG5_133787 All targets in OG5_133787
Echinococcus granulosus maternal embryonic leucine zipper kinase Get druggable targets OG5_133787 All targets in OG5_133787
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_133787 All targets in OG5_133787
Schistosoma mansoni serine/threonine kinase Get druggable targets OG5_133787 All targets in OG5_133787
Schistosoma japonicum ko:K08799 maternal embryonic leucine zipper kinase, putative Get druggable targets OG5_133787 All targets in OG5_133787
Loa Loa (eye worm) CAMK/CAMKL/MELK protein kinase Get druggable targets OG5_133787 All targets in OG5_133787

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi aldo/keto reductase, putative 0.0067 0.1796 0.5
Entamoeba histolytica aldose reductase, putative 0.0067 0.1796 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0067 0.1796 0.5
Echinococcus multilocularis maternal embryonic leucine zipper kinase 0.0099 0.5038 1
Leishmania major prostaglandin f2-alpha synthase/D-arabinose dehydrogenase 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Leishmania major aldo/keto reductase, putative,aldo/keto reductase family-like protein 0.0067 0.1796 0.5
Echinococcus granulosus voltage gated potassium channel subunit 0.0067 0.1796 0.3564
Trypanosoma brucei aldo-keto reductase, putative 0.0067 0.1796 0.5
Echinococcus granulosus hypothetical protein 0.0067 0.1796 0.3564
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Trypanosoma cruzi aldo/keto reductase, putative 0.0067 0.1796 0.5
Schistosoma mansoni aldo-keto reductase 0.0067 0.1796 0.1796
Onchocerca volvulus 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Giardia lamblia Aldose reductase 0.0067 0.1796 0.5
Schistosoma mansoni potassium channel beta 0.0067 0.1796 0.1796
Toxoplasma gondii aldo/keto reductase family oxidoreductase 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase 0.0067 0.1796 0.3564
Echinococcus granulosus maternal embryonic leucine zipper kinase 0.0099 0.5038 1
Plasmodium vivax aldehyde reductase, putative 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase 0.0067 0.1796 0.3564
Mycobacterium tuberculosis Conserved protein 0.0067 0.1796 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Onchocerca volvulus 0.0067 0.1796 0.5
Loa Loa (eye worm) CAMK/CAMKL/MELK protein kinase 0.0148 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Toxoplasma gondii oxidoreductase, aldo/keto reductase family protein 0.0067 0.1796 0.5
Toxoplasma gondii aldo-keto reductase 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase 0.0067 0.1796 0.3564
Leishmania major aldo-keto reductase-like protein 0.0067 0.1796 0.5
Schistosoma mansoni serine/threonine kinase 0.0148 1 1
Plasmodium vivax oxidoreductase, aldo/keto reductase domain containing protein 0.0067 0.1796 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0099 0.5038 0.3952
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Trypanosoma cruzi aldo-keto reductase 0.0067 0.1796 0.5
Mycobacterium ulcerans hypothetical protein 0.0067 0.1796 0.5
Entamoeba histolytica aldose reductase, putative 0.0067 0.1796 0.5
Entamoeba histolytica alcohol dehydrogenase, putative 0.0067 0.1796 0.5
Onchocerca volvulus 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Schistosoma mansoni aldo-keto reductase 0.0067 0.1796 0.1796
Entamoeba histolytica alcohol dehydrogenase, putative 0.0067 0.1796 0.5
Onchocerca volvulus 0.0067 0.1796 0.5
Plasmodium falciparum aldehyde reductase, putative 0.0067 0.1796 0.5
Echinococcus granulosus aldo keto reductase 0.0067 0.1796 0.3564
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Plasmodium falciparum aldo-keto reductase, putative 0.0067 0.1796 0.5
Onchocerca volvulus 0.0067 0.1796 0.5
Echinococcus granulosus aldo keto reductase 0.0067 0.1796 0.3564
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Leishmania major aldehyde reductase, putative,oxidoreductase, putative 0.0067 0.1796 0.5
Echinococcus granulosus aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Mycobacterium ulcerans oxidoreductase 0.0067 0.1796 0.5
Mycobacterium leprae Possible oxidoreductase 0.0067 0.1796 0.5
Mycobacterium leprae PROBABLE OXIDOREDUCTASE 0.0067 0.1796 0.5
Giardia lamblia Aldose reductase 0.0067 0.1796 0.5
Trypanosoma brucei prostaglandin f synthase 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase 0.0067 0.1796 0.3564
Trichomonas vaginalis CAMK family protein kinase 0.0148 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Leishmania major prostaglandin f synthase, putative 0.0067 0.1796 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564
Schistosoma mansoni pol-related 0.0067 0.1796 0.1796
Echinococcus multilocularis voltage gated potassium channel subunit 0.0067 0.1796 0.3564
Onchocerca volvulus 0.0067 0.1796 0.5
Onchocerca volvulus 0.0067 0.1796 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0099 0.5038 0.3952
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0067 0.1796 0.3564
Entamoeba histolytica aldose reductase, putative 0.0067 0.1796 0.5
Toxoplasma gondii aldose reductase, putative 0.0067 0.1796 0.5
Echinococcus granulosus aldo keto reductase 0.0067 0.1796 0.3564
Trypanosoma brucei aldo/keto reductase, putative 0.0067 0.1796 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0067 0.1796 0.3564

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 7.5 nM BindingDB_Patents: Kinase Assay. MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a substrate. The extent of FITC-labeled histone H3 peptide phosphorylation was measured by immobilized metal ion affinity-based fluorescence polarization (IMAP) technology (Sportsman J R, et al., Assay Drug Dev. Technol. 2: 205-14, 2004) using IMAP FP Progressive Binding System (Molecular Devices Corporation). Test compounds were dissolved in DMSO at 12.5 mM and then serially diluted as the DMSO concentration in the assays to be 1%. The serially diluted compounds, 0.8 ng/micro-L PBK (Carna Biosciences) and 100 nM FITC-labeled histone H3 peptide were reacted in a reaction buffer (20 mM HEPES, 0.01% Tween-20, 0.3 mM MgCl2, 2 mM dithiothreitol, 50 micro-M ATP, pH 7.4) at room temperature for 1 hour. The reaction was stopped by the addition of three fold assay volume of progressive binding solution. Following 0.5 hour incubation at room temperature. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.